Assessing Potential Risk for Men Taking Cialis

Drugs that dilate the blood vessels such as PDE5 inhibitors that are present in erectile dysfunction medications such as Cialis were the subject of investigation for coronary artery disease patients. The first of this type of medication to be patented was Viagra (Sildenafil). It was discovered that the medication has a beneficial effect on cardiovascular disease. Relaxation of the blood vessels which PDE5 inhibitors induce, is effective for the treatment of both erectile dysfunction and cardiovascular disease. Many studies have correlated the relationship of both conditions.

Cialis along with Viagra and Levitra are well established as oral treatments for erectile dysfunction. All three medications, which are all PDE5 inhibitors, have demonstrated high safety profiles and effectiveness. It is safe for men who suffer from chronic health conditions like high blood pressure, diabetes, inflammation and arteriosclerosis to take ED medications, so they are is often prescribed for erectile dysfunction with the added benefit of helping the chronic health issues. Cialis is generally the drug of choice for men with diabetes and cardiovascular disease due to its superior longevity. Many physicians prescribe a low dose of Cialis daily for men with these conditions to help to lower arterial pressure.

Chronic health conditions which occur concurrently with erectile dysfunction may include diabetes, depression. hypo-gonadism, vascular disease and high blood pressure. The most common factor that these men had was vascular disease. It is not surprising that occluded blood vessels which cause cardiovascular disease also cause other related conditions including erectile dysfunction.

The linkage between these common chronic health conditions and erectile dysfunction means that medical experts consider it crucial that men who present with erectile dysfunction are investigated for other related conditions. That is why erectile dysfunction medications are prescription medications. Doctors can screen for and diagnose the risk of cardiovascular disease in patients who have erectile dysfunction. Impotence may be the first sign that a patient may be suffering from cardiovascular disease or a related condition, so it would seem negligent not to use the early indicator of erectile dysfunction as an opportunity to assess the patients overall health.

In studies looking into the long term of PDE 5 inhibitors for periods of up to three years the medications were shown to be effective and safe. In the studies, any side effects were shown to be moderate and well tolerated. Importantly, the medications were shown to have no adverse effects on cardiovascular disease or related chronic health conditions.

PDE 5 inhibitors such as Cialis are able to safely treat erectile function even in patients who suffer from cardiovascular disease and other related chronic health conditions.